| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |